What Changed in the Market

Lam Research's next quarterly earnings report and gross margin guidance, particularly whether management confirms the potential 50%+ gross margin target cited in analyst commentary.

Confirm whether the CEO's sale timing and quantum-sector positioning (if material to APP's business) are addressed in any formal filings or earnings guidance updates; monitor close to see if +10.67% hold or reverses.

Monitor KLAC's fiscal Q3 2026 guidance and any analyst downgrades or price-target cuts in response to today's earnings call commentary on demand trends in chip equipment.

What changed: ROAD fell 9.04% to $108.03 with elevated volume (2.11x normal) in early trading on July 1, 2026. The decline occurred despite the company raising FY2026 guidance and expanding debt facilities, with analysts maintaining a bullish $150 fair value target.

Detected Jul 1, 3:11 PM ET

Source: Investing.com ↗

Closing price and volume confirmation; any management commentary on the guidance raise or debt facility expansion in coming days.

What changed: CPB gained 5.21% intraday to $23.43, coinciding with a reported positive analyst assessment of the company's growth strategy and announcement of a $0.39 cash dividend with an ex-date in July 2026.

Detected Jul 1, 3:11 PM ET

Source: Yahoo Finance ↗

Ex-dividend date in July 2026 and any earnings or quarterly guidance updates from Campbell Soup Company.

What changed: Celsius Holdings rose 8.82% intraday to $31.86, reversing a 1.54% decline from the prior session. The rebound coincides with published commentary on the company's 55% international revenue growth and confirmed Europe expansion (Spain launch via Suntory partnership, Portugal next).

Detected Jul 1, 3:11 PM ET

Source: Zacks ↗

Upcoming quarterly earnings report for detailed international segment breakdown and management guidance on Suntory partnership contribution and European market timing.

What changed: CORZ fell 5.49% to $24.18 intraday. Web search indicates an earnings miss drove the decline, with analyst consensus shifting to a $27 price target amid concerns over bitcoin market exposure.

Detected Jul 1, 3:11 PM ET

Source: MarketWatch ↗

Full earnings report and management guidance update; BTIG's revised stance given their recent $38 price target.

What changed: CNC jumped 5.21% intraday to $67.53. Yahoo Finance reported the stock surged 14.6% in the afternoon session, citing strong Q1 2026 earnings results and raised guidance.

Detected Jul 1, 3:11 PM ET

Source: Yahoo Finance ↗

Monitor for official earnings release details and any analyst rating or price-target changes in response to the Q1 2026 results.

What changed: TEM rose 6.37% to $61.62 on a Buy rating citing FDA approval for xT CDx's tumor-only indication and upcoming xH assay expansion for the AI diagnostics platform.

Detected Jul 1, 3:11 PM ET

Source: Seeking Alpha ↗

FDA approval timeline and commercial uptake data for the xH assay launch in 2026.

What changed: AAON reported Q1 2026 earnings with EPS of $0.48 (beating forecast by 6.67%) and revenue of $496.94M (30.4% above estimates), alongside record sales, backlog, and raised full-year guidance; the stock surged 45% pre-market but has since fallen 7.77% intraday to $117.01.

Detected Jul 1, 3:11 PM ET

Source: PR Newswire ↗

Monitor whether AAON stabilizes above $117 or continues lower into the close; track institutional trading flow and any follow-up analyst commentary on the valuation reset.

Intraday close confirmation and any commentary on whether the move sustains into tomorrow's session, plus monitoring for earnings or M&A announcements that could validate analyst targets.

Citigroup's full research note detailing the revised price target rationale and any revised financial estimates or sector outlook.